Biovision Ventures
Overview
Biovision Ventures is a venture capital investment firm based in Luxembourg. The firm prefers to invest in therapeutics and biotechnology sector companies based in the United States and Europe. They support innovative early-stage companies with a mission to translate groundbreaking science into transformative therapies. They focus on private companies in the US and Europe as key innovation hubs, with the goal of identifying global technological leaders regardless of their location.
Portfolio Companies
7
Website
biovision.vcInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Tune Therapeutics | Jan 2025 | Series B | Co-investor |
| Solu Therapeutics | Apr 2025 | Series A | Co-investor |
| Sorriso Pharmaceuticals | Dec 2021 | Series A | Co-investor |
| Arda Therapeutics | Oct 2024 | Series A | Co-investor |
| Radar Therapeutics | May 2024 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Alexey Konov
Managing Partner
Robert Karl
Venture Partner
Igor Gonikhin
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Biovision Ventures based?
Biovision Ventures is headquartered in Luxembourg, Canton of Luxembourg, Luxembourg.
When was Biovision Ventures founded?
Founding year information for Biovision Ventures is not publicly available.
How many portfolio companies does Biovision Ventures have?
Biovision Ventures has 7 portfolio companies in Caplight's dataset.
What are some companies in Biovision Ventures's portfolio?
Portfolio companies visible on Caplight include Tune Therapeutics, Solu Therapeutics, Sorriso Pharmaceuticals, Arda Therapeutics, Radar Therapeutics.
What was Biovision Ventures's most recent investment shown here?
Biovision Ventures's most recent investment in this portfolio sample was in Solu Therapeutics in 2025.
What sectors does Biovision Ventures focus on?
Biovision Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Biovision Ventures focus on?
Biovision Ventures typically invests at the Early stage.
What is Biovision Ventures's AUM?
Biovision Ventures's assets under management are estimated between $50.0M and $100.0M.